Page 2 - Phase 3 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 3 Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 3 Trial Today - Breaking & Trending Today

Takeda pulls lung cancer drug from market

Published: October 3, 2023

Takeda Pharmaceuticals voluntarily withdraws Exkivity (mobocertinib) in the U.S. after a phase 3 trial failed to confirm the lung cancer drug's efficacy.

Source: beckershospitalreview.com

Chikungunya vaccine provokes immune response in phase 3 trial

Published: July 5, 2023

A vaccine candidate for chikungunya disease has been found to produce an immune response in 99% of phase 3 trial participants.

Source: labonline.com.au

Oral medication for Crohn's disease approved by FDA

Published: June 7, 2023

Patients with moderate-to-severe Crohn's disease now have a new treatment option to suppress their intestinal inflammation and help them maintain their relief.

Source: labonline.com.au